Publisher: Icon Group International, Inc.
Category: Diseases & Conditions

Diseases & Conditions market research reports by Icon Group International, Inc.

(630 reports matching your criteria)
    • The 2025-2030 World Outlook for Diabetes Treatments

      The 2025-2030 World Outlook for Diabetes Treatments This study covers the world outlook for diabetes treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More

    • The 2025-2030 World Outlook for Cold, Cough, and Sore Throat Remedies

      The 2025-2030 World Outlook for Cold, Cough, and Sore Throat Remedies This study covers the world outlook for cold, cough, and sore throat remedies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the coun ... Read More

    • The 2025-2030 World Outlook for Melanoma Therapeutics

      The 2025-2030 World Outlook for Melanoma Therapeutics This study covers the world outlook for melanoma therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More

    • The 2025-2030 World Outlook for Systematic Lupus Erythematosus Treatments

      The 2025-2030 World Outlook for Systematic Lupus Erythematosus Treatments This study covers the world outlook for systematic Lupus erythematosus treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for ... Read More

    • The 2025-2030 World Outlook for Disease-Specific Chronic Myelogenous Leukemia Treatments

      The 2025-2030 World Outlook for Disease-Specific Chronic Myelogenous Leukemia Treatments This study covers the world outlook for disease-specific chronic myelogenous leukemia treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential in ... Read More

    • The 2025-2030 World Outlook for Non-Small Cell Lung Cancer Therapeutics

      The 2025-2030 World Outlook for Non-Small Cell Lung Cancer Therapeutics This study covers the world outlook for non-small cell lung cancer therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the ... Read More

    • The 2025-2030 World Outlook for Non-Steroidal Anti-Inflammatory Drugs Segment - Topical Pain Relief

      The 2025-2030 World Outlook for Non-Steroidal Anti-Inflammatory Drugs Segment - Topical Pain Relief This study covers the world outlook for non-steroidal anti-inflammatory drugs segment - topical pain relief across more than 190 countries. For each year reported, estimates are given for the latent d ... Read More

    • The 2025-2030 World Outlook for IBD (Ulcerative Colitis and Crohn's Disease) Treatments

      The 2025-2030 World Outlook for IBD (Ulcerative Colitis and Crohn's Disease) Treatments This study covers the world outlook for IBD (ulcerative colitis and Crohn's disease) treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential indu ... Read More

    • The 2025-2030 World Outlook for Prostate Cancer Therapeutics

      The 2025-2030 World Outlook for Prostate Cancer Therapeutics This study covers the world outlook for prostate cancer therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (i ... Read More

    • The 2025-2030 World Outlook for Prostate Cancer Treatments

      The 2025-2030 World Outlook for Prostate Cancer Treatments This study covers the world outlook for prostate cancer treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mi ... Read More

    • The 2025-2030 World Outlook for Dengue Vaccine for Age Group >12 Years

      The 2025-2030 World Outlook for Dengue Vaccine for Age Group >12 Years This study covers the world outlook for dengue vaccine for age group >12 years across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the co ... Read More

    • The 2025-2030 World Outlook for Disposable Blood Pressure Transducers

      The 2025-2030 World Outlook for Disposable Blood Pressure Transducers This study covers the world outlook for disposable blood pressure transducers across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the coun ... Read More

    • The 2025-2030 World Outlook for Pancreatic Cancer Treatments

      The 2025-2030 World Outlook for Pancreatic Cancer Treatments This study covers the world outlook for pancreatic cancer treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (i ... Read More

    • The 2025-2030 World Outlook for Chemotherapy for Endometrial Cancers

      The 2025-2030 World Outlook for Chemotherapy for Endometrial Cancers This study covers the world outlook for chemotherapy for endometrial cancers across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the countr ... Read More

    • The 2025-2030 World Outlook for Substance Abuse Therapeutics

      The 2025-2030 World Outlook for Substance Abuse Therapeutics This study covers the world outlook for substance abuse therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (i ... Read More

    • The 2025-2030 World Outlook for Hemophilia Drugs

      The 2025-2030 World Outlook for Hemophilia Drugs This study covers the world outlook for hemophilia drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dolla ... Read More

    • The 2025-2030 World Outlook for Sphygmomanometers

      The 2025-2030 World Outlook for Sphygmomanometers This study covers the world outlook for sphygmomanometers across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dol ... Read More

    • The 2025-2030 World Outlook for Herpes Marker Testing

      The 2025-2030 World Outlook for Herpes Marker Testing This study covers the world outlook for herpes marker testing across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More

    • The 2025-2030 World Outlook for Cancer-Treating Drugs

      The 2025-2030 World Outlook for Cancer-Treating Drugs This study covers the world outlook for cancer-treating drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More

    • The 2025-2030 World Outlook for Herpes Simplex Virus Infections

      The 2025-2030 World Outlook for Herpes Simplex Virus Infections This study covers the world outlook for herpes simplex virus infections across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in quest ... Read More

    • The 2025-2030 World Outlook for Liver Cancer Diagnostics

      The 2025-2030 World Outlook for Liver Cancer Diagnostics This study covers the world outlook for liver cancer diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millio ... Read More

    • The 2025-2030 World Outlook for Liver Cancer Drugs

      The 2025-2030 World Outlook for Liver Cancer Drugs This study covers the world outlook for liver cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. d ... Read More

    • The 2025-2030 World Outlook for Hepatitis C Treatments

      The 2025-2030 World Outlook for Hepatitis C Treatments This study covers the world outlook for hepatitis c treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions o ... Read More

    • The 2025-2030 World Outlook for Hepatitis Diagnostics

      The 2025-2030 World Outlook for Hepatitis Diagnostics This study covers the world outlook for hepatitis diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More

    • The 2025-2030 World Outlook for Hepatitis Therapeutics

      The 2025-2030 World Outlook for Hepatitis Therapeutics This study covers the world outlook for hepatitis therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions o ... Read More

1 2 3 4 5 6 7 8 9 10

Cookie Settings